دورية أكاديمية

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens

التفاصيل البيبلوغرافية
العنوان: First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
المؤلفون: S001 Study Team, Nyombayire, Julien, Anzala, Omu, Gazzard, Brian, Karita, Etienne, Bergin, Philip, Hayes, Peter, Kopycinski, Jakub, Omosa-Manyonyi, Gloria, Jackson, Akil, Bizimana, Jean, Farah, Bashir, Sayeed, Eddy, Parks, Christopher L., Inoue, Makoto, Hironaka, Takashi, Hara, Hiroto, Shu, Tsugumine, Matano, Tetsuro, Dally, Len, Barin, Burc, Park, Harriet, Gilmour, Jill, Lombardo, Angela, Excler, Jean-Louis, Fast, Patricia, Laufer, Dagna S., Cox, Josephine H.
المصدر: The Journal of Infectious Diseases, 2017 Jan 01. 215(1), 95-104.
الوصول الحر: https://www.jstor.org/stable/26166799Test
قاعدة البيانات: JSTOR Journals